Biotech

All Articles

Turnstone gives up 60%, shocks C-suite to extend money

.Turnstone Biologics is reducing its head count through 60% and shocking its own C-suite to always k...

Gilead gives up on $15M MASH bet after weighing preclinical data

.In a year that has seen an approval and a plethora of readouts for metabolic dysfunction-associated...

Texas biotech axes cancer cells deal, pins really hopes on weight problems

.Alaunos Therapies is actually axing an agreement along with Precigen, surrendering licensing legal ...

Capricor portions much more information for DMD treatment after launching BLA

.Capricor Therapies is actually taking a triumph tour for their stage 2 Duchenne muscular dystrophy ...

FDA places Kezar lupus test in grip complying with 4 patient deaths

.The FDA has actually placed Kezar Lifestyle Sciences' lupus trial on hold after the biotech flagged...

Phase 3 Scholar Stone trial reaches SMA goal, delivering stockpile 200%

.A stage 3 trial of Scholar Rock's spine muscle degeneration (SMA) prospect has actually struck its ...

CAMP 4 is actually most up-to-date to eye IPO, while Upstream spells out $182M program

.RNA biotech CAMP4 Therapeutics has actually marked out plans for a $67 thousand IPO, along with inf...

Galecto purchases leukemia medication, loses bone tissue cancer cells asset in pivot

.A year after the breakdown of an idiopathic lung fibrosis candidate delivered Galecto on a look for...

Judo tosses down $100M to knock out kidney condition

.Taking the mat is actually Judo Biography, an up-and-coming biotech armed along with $100 million t...

AstraZeneca pays out CSPC $100M for preclinical heart problem medication

.AstraZeneca has actually paid off CSPC Pharmaceutical Team $one hundred million for a preclinical c...